Articles
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Under a Creative Commons license
open access
Cited by (0)
- *
-
Contributed equally
- †
-
Members are listed in appendix 1 (pp 21–44)
© 2020 The Author(s). Published by Elsevier Ltd.